Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2008-01-30 Regulatory Filings
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 11, 2008. It reports the approval by shareholders of amendments to the company's Articles of Incorporation to increase authorized common and preferred stock. The document includes the filing of restated Articles of Incorporation as an exhibit. The content focuses on corporate governance changes related to capital structure but does not contain financial statements or detailed financial analysis. The document length is 2963 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. This type of filing is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about corporate changes and does not fit into more specific categories like Share Issue/Capital Change (SHA) since it is about amendments and restatements rather than new share issuance or capital changes per se. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2008-01-30 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 27, 2007. It reports an amendment and restatement of the company's bylaws to comply with a Nasdaq rule regarding Direct Registration System eligibility. The document includes a description of the bylaw changes and references the full text of the amended bylaws filed as an exhibit. There are no financial statements or detailed financial data presented. The content focuses on corporate governance changes related to bylaws, not a full management or board change announcement. Given the nature of the amendment to bylaws and the filing type (8-K), this fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other more specific categories such as Board/Management Information or Governance Information, since it is a regulatory filing of bylaw amendment rather than a governance report. The document length is 4108 characters, which is relatively short and consistent with a regulatory filing rather than a full report.
2007-12-28 English
Proxy Solicitation & Information Statement 2007
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed with the SEC. It specifically mentions it is a "Definitive Additional Materials" related to a special meeting of shareholders, urging shareholders to vote on proposals such as increasing authorized shares. It references the definitive proxy statement filed earlier and encourages shareholders to read it. The document is not the proxy statement itself but additional solicitation materials related to the proxy. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is about 5300 characters, consistent with a solicitation letter rather than a full proxy statement. Therefore, the correct classification is PSI with high confidence.
2007-12-27 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text references an announcement about the results of a committee's assessment related to a clinical trial adverse event, and includes a press release as an exhibit. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a certification or a proxy statement, nor does it relate to board changes, mergers, or dividends. Given the nature of the content and the form type, this is a Regulatory Filing (RNS) as it reports a material event without fitting into other specific categories.
2007-12-06 English
Regulatory Filings 2007
Regulatory Filings Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, which is used to announce major events that shareholders should know about. The content describes an announcement regarding the FDA removing a hold on a clinical trial, and it includes a press release as an exhibit. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is an event-driven regulatory filing reporting a material event, typical of an 8-K filing. Given the nature and length (2433 characters), it is not a full financial report but a regulatory announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2007-11-26 English
Proxy Solicitation & Information Statement 2007
Proxy Solicitation & Information Statement
2007-11-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.